Concepedia

Yan Li

YL

37

Publications

1.3K

Citations

20

H-Index

2008

Active since

Affiliations

Bristol-Myers Squibb (Switzerland)(Current)

The University of Texas MD Anderson Cancer Center

Nankai University

Hackensack University Medical Center

Emory University

Yan Li is an author at Bristol-Myers Squibb (Switzerland) specializing in medicine, pharmacology, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryImmunologyBiochemistryOncologyPharmacotherapyNatural SciencesMedicinal ChemistryBiomolecular Engineering

Publications per year

2008–2024

37

Publications

37

In Vitro Approach to Assess the Potential for Risk of Idiosyncratic Adverse Reactions Caused by Candidate Drugs

Richard A. Thompson, Emre M. Isin, Yan Li et al. · Chemical Research in Toxicology · 2012 · 212 citations

Immunology, Pharmacotherapy, Iadrs Arise +21

Risk assessment and mitigation strategies for reactive metabolites in drug discovery and development

Richard A. Thompson, Emre M. Isin, Yan Li et al. · Chemico-Biological Interactions · 2010 · 102 citations

Risk Assessment, Reactive Metabolites, Predictive Toxicology +10

IL-6 receptor expression and IL-6 effects change during osteoblast differentiation

Yan Li, Carl‐Magnus Bäckesjö, Lars-Arne Haldosén et al. · Cytokine · 2008 · 73 citations

Inflammation, Sclerostin, Bone Morphogenic Protein +9

Development of a Brigatinib degrader (SIAIS117) as a potential treatment for ALK positive cancer resistance

Ning Sun, Chaowei Ren, Ying Kong et al. · European Journal of Medicinal Chemistry · 2020 · 72 citations · Full text

Medicine, Pharmacology, Brigatinib Degrader +6

Chemoselective Synthesis of Lenalidomide-Based PROTAC Library Using Alkylation Reaction

Xing Qiu, Ning Sun, Ying Kong et al. · Organic Letters · 2019 · 71 citations

Medicinal Chemistry, Chemoselective Synthesis, Bet Protein +11

Rows per page

1–5 of 37